Portal de Periódicos da CAPES

Alcohol‐Induced Liver Disease

1985; Wiley; Volume: 9; Issue: 1 Linguagem: Inglês

10.1111/j.1530-0277.1985.tb05052.x

1530-0277

David Frank, Robert F. Raicht,

Alcoholism and Thiamine Deficiency

Alcoholism: Clinical and Experimental ResearchVolume 9, Issue 1 p. 66-82 Alcohol-Induced Liver Disease David Frank MD, David Frank MD Department of Medicine. New York Veterans Administration Medical Center and New York University Medical Center, New York, NYSearch for more papers by this authorRobert F. Raicht MD, Corresponding Author Robert F. Raicht MD Department of Medicine. New York Veterans Administration Medical Center and New York University Medical Center, New York, NYRobert F. Raicht, M.D., VA. Medical Center, 408 First Avenue. New York, NY 10010Search for more papers by this author David Frank MD, David Frank MD Department of Medicine. New York Veterans Administration Medical Center and New York University Medical Center, New York, NYSearch for more papers by this authorRobert F. Raicht MD, Corresponding Author Robert F. Raicht MD Department of Medicine. New York Veterans Administration Medical Center and New York University Medical Center, New York, NYRobert F. Raicht, M.D., VA. Medical Center, 408 First Avenue. New York, NY 10010Search for more papers by this author First published: January 1985 https://doi.org/10.1111/j.1530-0277.1985.tb05052.xCitations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 National Institute of Alcoholism and Alcohol Abuse: Third Special Report to the U. S. Congress on Alcohol and Health from the Secretary of the Department of Health, Education, and Welfare. Washington , DC , US Government Printing Office, 1978. 2 West LJ, Maxwell, DS, Noble ER, Solomon DH: Alcoholism. Ann Intern Med 100: 405–406, 1984. 3 Lieber CS, Leo MA: Alcohol and the liver, in CS Lieber (ed): Major Problems in Internal Medicine, vol 22. Philadelphia , WB Saunders Co, pp 259-312, 1982. 4 City of New York, Department of Health: Summary of Vital Statistics of the City of New York. New York , Bureau of Health Statistics and Analysis, 1981. 5 Gallagher RP, Elwood JM: Increases in alcohol related mortality in Canada, 1965–77. Lancet 1: 775–776, 1980. 6 Pequinot G, Tuyns AJ, Berta JL: Ascitic cirrhosis in relation to alcohol consumption. Int J Epidemiol 7: 113–120, 1978. 7 Pequinot G, Tuyns AJ: Compared toxicity of ethanol on various organs, in C Stock, H Sarles (eds): Alcohol and the Gastrointestinal Tract. Paris , INSERM, p 17, 1980. 8 Mezey E: Alcoholic liver disease, in H Popper, F Shaffner (eds): Progress in Liver Disease. New York , Grune & Stratton, pp 555-572, 1982. 9 French SW, Burbige EJ: Alcoholic hepatitis: clinical, morphologic, pathogenic and therapeutic agents, in H Popper, F Shaffner (eds): Progress in Liver Disease, vol VI. New York , Grune & Stratton, p 557, 1979. 10 Geokas MC, Lieber CS, French S, Halsted CH: Ethanol, the liver, and the gastrointestinal tract. Ann Intern Med 95: 198–211, 1981. 11 Orrego H, Israel Y, Blendis LM: Alcoholic liver disease: information in search of knowledge. Hepatology 1: 267–283, 1981. 12 Green JR: Subclinical acute liver disease of the alcoholic. Aust Ann Med 14: 111–124, 1965. 13 Knott DH, Beard JD: Liver function in apparently healthy chronic alcoholic patients. Am J Med Sci 252: 260–264, 1966. 14 Rankin JGD, Orrego-Matte H, Deschenes J, Medline A, Findlay JE, Armstrong AIM: Alcoholic liver disease: the problem of diagnosis. Alcoholism: Clin Exp Res 2: 327–338, 1978. 15 Popper H, Szanto PB: Fatty liver with hepatic failure in alcoholics. J Mt Sinai Hosp 24: 1121, 1957. 16 Ballard H, Bernstein M, Farrar JT: Fatty liver presenting as obstructive jaundice. Am J Med 30: 196–201, 1971. 17 Morgan MY, Sherlock S, Scheuer PJ: Acute cholestasis, hepatic failure and fatty liver in the alcoholic. Scand J Gastroenterol 13: 299–303, 1978. 18 Kryger P, Schlichting P, Dietrichson O, Juhl E: The accuracy of the clinical diagnosis in acute hepatitis and alcoholic liver disease. Scand J Gastroenterol 18: 691–696, 1983. 19 Levin DM, Baker AL, Riddell RH, Rochman H, Boyer JL: Nonalcoholic liver disease: overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med 66: 429–434, 1979. 20 Missl PR, Pennington TH, Kay P, MacSween RNM, Watkinson G: Hepatitis B antibody in alcoholic cirrhosis. J Clin Pathol 32: 778–782, 1979. 21 Hislop WS, Follett EAC, Boucher IAD, MacSween RNM: Serological markers of hepatitis B in patients with alcoholic liver disease: a multi-centre survey. J Clin Pathol 34: 1017–1019, 1981. 22 Gluud C, Aldershvile J, Henriksen J, Kryger P, Mathiesen L: Hepatitis B and A virus antibodies in alcoholic steatosis and cirrhosis. J Clin Pathol 35: 693–697, 1982. 23 Popper H, Thung SN, Gerber MA: Pathology of alcoholic liver diseases. Semin Liver Dis 1: 203–216, 1981. 24 Review by an International Group: Alcoholic liver disease: morphological manifestations. Lancet 1: 707–711, 1981. 25 Sheuer PJ: Liver Biopsy Interpretation. London , Cassell Ltd, 1980. 26 Popper H, Lieber CS: Histogenesis of alcoholic fibrosis and cirrhosis in the baboon. Am J Pathol 98: 695–716, 1980. 27 van Waes L, Lieber CS: Early perivenular sclerosis in alcoholic fatty liver an index of progressive liver injury. Gastroenterology 73: 646–650, 1977. 28 Nakano M, Worner TM, Lieber CS: Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression. Gastroenterology 83: 777–785, 1982. 29 Uchida T, Kao H, Quispe-Sjogren M, Peters R: Alcoholic foamy degeneration. Gastroenterology 84: 683–692, 1983. 30 Birschbach HR, Harinasuta U, Zimmerman HJ: Alcoholic stea-tonecrosis. II. Prospective study of prevalence of Mallory bodies in biopsy specimens and comparison of severity of hepatic disease in patients with and without this histological feature. Gastroenterology 66: 1195–1202, 1974. 31 Edmondson HA, Peters RL, Reynolds TB, Kuzma OT: Sclerosing hyaline necrosis of the liver in the chronic alcoholic. A recognizable syndrome. Ann Intern Med 59: 646–673, 1963. 32 Stewart RV, Dincsoy HP: The significance of giant mitochondria in liver biopsies as observed by light microscopy. Am J Clin Pathol 78: 293–298, 1982. 33 Gerber MA, Orr W, Denk H, Schaffner F, Popper H: Hepatocellular hyalin in cholestasis and cirrhosis: its diagnostic significance. Gastroenterology 64: 89–98, 1973. 34 Lewis D, Wainwright HC, Kew MC, Zwi S, Isaacson C: Liver damage associated with perhexiline maleate. Gut 20: 186–189, 1979. 35 Peters RL, Gay T, Reynolds TB: Post-jejunoileal-bypass hepatic disease. Its similarity to alcoholic hepatic disease. Am J Clin Pathol 63: 318–331, 1975. 36 Falchuk KR, Fiske S, Trey C, Haggitt R, Federman M: Pericentral hepatic fibrosis in diabetes mellitus. Gastroenterology 72: 1174 (Abstr 151)1977. 37 Galambos JT: Natural history of alcoholic hepatitis. III. Histological changes. Gastroenterology 63: 1026–1035, 1972. 38 Boitnott JK, Maddrey WC: Alcoholic liver disease. I. Interrelationships among histologic features and histologic effects of prednisone therapy. Hepatology 1: 599–612, 1981. 39 Afshani P, Littenberg GD, Wollman J, Kaplowitz N: Significance of microscopic cholangitis in alcoholic liver disease. Gastroenterology 75: 1045–1050, 1978. 40 Boitnott JK: Morphologic aspects of alcoholic liver disease in course of alcoholism and alcohol-induced liver disease. American Association for the Study of Liver Diseases: Postgraduate Course, 1981. Morphologic Aspects of Alcoholic Liver Diseases, pp 150-157. 41 Goldberg SJ, Mendenhall CL, Connell AM, Chedid A: “Nonalcoholic” chronic hepatitis in the alcoholic. Gastroenterology 72: 598–604, 1977. 42 Nei J, Matsuda Y, Takada A: Chronic hepatitis induced by alcohol. Digest Dis Sci 28: 207–214, 1983. 43 Popper H: The pathogenesis of alcoholic cirrhosis, in MM Fisher, JG Rankin (eds): Alcohol and the Liver. New York , Plenum Press, pp 289-305, 1977. 44 Reynolds TB. Hidemara R, Michel H, Peters R: Portal hypertension without cirrhosis in alcoholic liver disease. Ann Intern Med 70: 497–506, 1969. 45 Goodman ZD, Ishak KG: Occlusive venous lesions in alcoholic liver disease. A study of 200 cases. Gastroenterology 83: 786–796, 1982. 46 Lieber CS: Metabolism and metabolic effects of ethanol. Semin Liver Dis 1: 189–201, 1981. 47 Lieber CS, Spritz N: Effects of prolonged ethanol intake in man: role of dietary, adipose, and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver. J Clin Invest 45: 1400–1411, 1966. 48 Rothschild MA, Oratz M, Morland J, Schreiber SS, Burks A, Martin B: Effects of ethanol on protein synthesis and secretion. Pharm Biochem Behav 13: 31-36 (suppl) 1980. 49 Rothschild MA, Oratz M, Schreiber SS: Albumin synthesis studies in livers from rabbits chronically exposed to ETOH. Gastroenterology 77: A35 (abstr) 1979. 50 Baraona E, Leo MA, Borowsky SA, Lieber CS: Pathogenesis of alcohol-induced accumulation of protein in the liver. J Clin Invest 60: 546–554, 1977. 51 Baraona E, Leo MA, Borowsky SA, Lieber CS: Alcoholic hepatomegaly: accumulation of protein in the liver. Science 190: 794–795, 1975. 52 Israel Y, Britton RS. Orrego H: Liver cell enlargement induced by chronic alcohol consumption: studies on its causes and consequences. Din Biochem 15: 189–192, 1982. 53 Iseri OA, Lieber CS, Gottlieb LS: The ultrastructure of fatty liver induced by prolonged ethanol ingestion. Am J Pathol 48: 535–555, 1966. 54 Lieber CS, Seitz HK, Garrov AJ, Woyncr TM: Alcohol-related diseases and carcinogenesis. Cancer Res 39: 2863–2886, 1979. 55 French SW: Role of mitochondrial damage in alcoholic liver disease, in E Majchrowicz, EP Noble (eds): Biochemistry and Pharmacology of Ethanol, vol 1. New York , Plenum Publishers, 1979. 56 Jenkins WJ, Peters TJ: Mitochondrial enzyme activities in liver biopsies from patients with alcoholic liver disease. Gut 19: 341–344, 1978. 57 Arai M, Leo MA, Nakano M, Gordon ER, Lieber CS: Biochemical and morphological alterations of baboon hepatic mitochondria after chronic ethanol consumption. Hepatology 4: 165–174, 1984. 58 Bernstein J, Penniall R: Effects of chronic ethanol treatment upon rat liver mitrochondria. Biochem Pharmacol 27: 2342, 1978. 59 Korstem M, Matsuzaki L, Feinman L, Lieber CS: High blood acetaldehyde levels following ethanol administration: differences between alcoholic and nonalcoholic subjects. N Engl J Med 292: 586, 1975. 60 Pikkaraincn PH, Saiaspuro MP, Lieber CS: A method for the determination of “free” acetaldehyde in plasma. Alcoholism 8: 13–27, 1973. 61 Ericksson CJP: Problems and pitfalls in acetaldehyde determinations. Alcoholism: Clin Exp Res 4: 22–29, 1980. 62 Sorrell MF, Leevy CM: Lymphocyte transformation and alcoholic liver injury. Gastroenterology 63: 1020–1025, 1972. 63 Kakomi S, Leevy CM: Lymphocyte cytotoxicity in alcoholic hepatitis. Gastroenterology 72: 594–597, 1977. 64 Israel Y, Videla L, MacDonald A: Metabolic alteration produced in the liver by chronic ethanol administration: Comparison between the effects produced by ethanol and by thryoid hormones. Biochem J 134: 523–529, 1973. 65 Israel Y, Kalant H, Orrego H: Experimental alcohol induced hepatic necrosis: suppression by propylthiouracil. Proc Natl Acad Sci USA 72: 1137–1141, 1975. 66 Orrego H, Kalant H, Israel Y, Blake J, Medline A, Rankin JG, Armstrong A, Kapur B: Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease. Gastroenterology 76: 105–115, 1979. 67 Israel Y, Walfish PG, Orrego H, Blake J, Kalant H: Thyroid hormones in alcoholic liver disease: effect of treatment with 6-n-propyl-thiouracil. Gastroenterology 76: 112–122, 1979. 68 Hallé P, Paré P, Kaptein E, Kanel G, Redeker AG, Reynolds RB: Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis. Gastroenterology 82: 925–931, 1982. 69 Teschke R, Moreno F, Heiner E, Herrmann J, Kroskemper HL, Strohmeger G: Hepatic thyroid hormone levels following chronic alcohol consumption: direct experimental evidence in rats against the existence of a hyperthyroid hepatic state. Hepatology 3: 469–474, 1983. 70 French SW; The Mallory body: Structure, corporation, and pathogenesis. Hepatology 1: 76–83, 1981. 71 Leevy CM, Chen T: Ethanol inhibition on liver regeneration. Gastroenterology 77: 1151–1153, 1979. 72 Leevy CM: Abnormalities of hepatic DNA synthesis in man. Medicine (Baltimore) 45: 423–433, 1966. 73 Leevy CM, Kanagasundaram, Smith F: Treatment of liver disease of the alcoholic: a composite approach. Semin Liver Dis 1: 254–266, 1981. 74 Agarwal DP, Haranda S. Goedde HW: Racial differences in biological sensitivity to ethanol: the role of alcohol dehydrogenase and aldehyde dehydrogenase isoenzymes. Alcoholism: Clin Exp Res 5: 12–16, 1981. 75 Harada S, Agarwal DP, Goeede HW: Aldehyde dehydrogenase deficiency as cause of facial flushing reaction to alcohol in Japanese. Lancet 2: 982, 1981. 76 MacRay I: Genetic aspects of immunologically mediated liver disease. Semin Liver Dis 4: 13–25, 1984. 77 Faizallah R, Woodrow JC, Krasner NK, Walker RJ, Morris AL: Are HLA antigens important in the development of alcohol-induced liver disease Br Med J 285: 533–534, 1982. 78 Tait BD, MacKay IR: HLA and alcoholic cirrhosis. Tissue Antigens 19: 6–10, 1982. 79 Zetterman RK, Sorrell MF: Immunologic aspects of alcoholic liver disease. Gastroenterology 81: 616–624, 1981. 80 Wands JR, Dienstag JL, Weake JR, Koff RS: Proliferative and secretory B cell activity in severe alcoholic liver disease. Gastroenterology 75: 992 (abstr) 1978. 81 Neuberger J, Crossley IR, Saunders JB, Davis M, Portmann B, Eddleston ALWF, Williams R: Antibodies to alcohol altered liver cell determinants in patients with alcoholic liver disease. Gut 25: 300–304, 1984. 82 Si L, Whiteside TL, Schade RR, VanThiel DA: Lymphocyte subsets studied with monoclonal antibodies in liver tissues of patients with alcoholic cirrhosis. Hepatology 2: 711 (abstr) 1982. 83 Peters M, Liebman HA, Tong MJ, Tinberg HM: Alcoholic hepatitis: granulocyte chemotactic factor from Mallory body-stimulated human peripheral blood mononuclear cells. Clin Immunol Immuno pathol 28: 418–430, 1983. 84 Kawanishi H, Tavassolie H, MacDermott RP, Sheagren JN: Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease. Gastroenterology 80: 510–517, 1981. 85 Sherlock S: Alcohol-related liver disease. Clinical aspects and management Br Med Bull 38: 67–70, 1982. 86 Stephens DH, Sheeder PF, Hattery RR, MacCarty RL: Computed tomography of the liver. Am J Roentgenol 128: 579–580, 1977. 87 Bydder GM, Kreel L, Chapman RWG, Harry D, Sherlock S. Bassan L: Accuracy of computed tomography in diagnosis of fatty liver. Br Med J 281: 1042, 1980. 88 Harbin WP, Robert NJ, Ferruci JT: Diagnosis of cirrhosis based on regional changes in hepatic morphology. Radiology 135: 273–283, 1980. 89 Balthazar EJ, Megiban A, Naidica D, LeFleur RS: Computed tomographic recognition of gastric varices. Am J Roentgenol 142: 1121–1125, 1984. 90 Aisen AM, Martel W, Glazer GM, Carson PL: Hepatic imaging: positron emission tomography, digital angiography and nuclear magnetic resonance imaging. Hepatology 3: 1024–1030, 1983. 91 Friedman MS, Falkenstein DB, Zimmon DS: Bile duct obstruction in alcoholic liver disease: The role of ERCP. Gastroenterology 79: 1017 (abstr) 1980. 92 Jeffers LI, Schiff ER: Evaluation of invasive diagnostic procedures in alcoholic liver disease. Alcoholism: Clin Exp Res 5: 131-136, 1981. 93 O'Connor KW, Snodgrass PJ, Swonder JE, Mahoney S, Burt R, Cockerill EM, Lumeng L: A blinded prospective study comparing four current non-invasive approaches in the differential diagnosis of medical versus surgical jaundice. Gastroenterology 84: 1498–1504, 1983. 94 Vennes JA, Bond JH (editorial): Approach to the jaundiced patient. Gastroenterology 84: 1615–1618, 1983. 95 Afroudakis A, Kaplowitz N: Liver histology in chronic common bile duct stenosis due to chronic alcoholic pancreatitis. Hepatology 1: 65–72, 1981. 96 Larkin EC, Watson-Williams EJ: Alcohol and the blood. Med Clin N Am 68: 105–120, 1984. 97 Patek AJ, Hermos JA: Recovery from alcoholism in cirrhotic patients. A study of 45 cases. Am J Med 70: 782–785, 1981. 98 Schenker S: Alcoholic liver disease: evaluation of natural history and prognostic factors. Hepatology 4: 365–435, 1984. 99 Hislop WS, Bouchier IAD, Allan JG, Brunt PW, Eastwood M, Finlayson NDC, James O, Russell RI, Watkinson G: Alcoholic liver disease in Scotland and Northeastern England: presenting features in 510 patients. Q J Med New Ser LII: 232-243, 1983. 100 Bunout D, Gattas V, Innriaga H, Perez C, Pereda T. Ugarte G: Nutritional status of alcoholic patients: its possible relationship to alcoholic liver damage. Am J Clin Nutr 38: 469–473, 1983. 101 Sherlock S: Nutrition and the alcoholic. Lancet 2: 436–438, 1984. 102 Burbridge EJ, Lewis DR, Halstead LH: Alcohol and the gastrointestinal tract. Med Clin N Am 68: 77–89, 1984. 103 Morgan MY: Alcohol and nutrition. Br Med Bull 38: 21–29, 1982. 104 Green PHR: Drugs, alcohol and malabsorption. Am J Med 67: 1066–1074, 1979. 105 Rubin E, Rybak BJ, Lindenbaum J, Cerson CD, Walker G, Lieber CS: Ultrastructural changes in the small intestine induced by ethanol. Gastroenterology 63: 801–814, 1972. 106 Baraona E, Pirola RC, Lieber CS: Small intestinal damage and changes in cell population produced by ethanol ingestion in the rat. Gastroenterology 66: 226–234, 1974. 107 Perlow W, Baraona E, Lieber CS: Symptomatic intestinal dis-saccharidase deficiency in alcoholics. Gastroenterology 72: 680–684, 1977. 108 Greene HL, Stifel FB, Herman RH, Herman YF, Rosensweig NS: Ethanol induced inhibition of human intestinal enzyme activities: reversal by folic acid. Gastroenterology 67: 434–440, 1979. 109 Hoyumpa AM, Nichols SG, Wilson FA, Schenker S: Effect of ethanol on intestinal Na, K.-ATPase and intestinal thiamine transport in rats. J Lab Clin Med 90: 1086–1095, 1977. 110 Green PHR: Alcohol, nutrition and malabsorption. Clin Gastroenterol 12: 563–574, 1983. 111 Halsted CH, Chandler C, Wang T, Beer WH, Dwivedi C: Brush border conjugase: a zinc activated enzyme. Gastroenterology 84: 1179 (abstr) 1983. 112 Pirola RC, Davis AR: Effects of intravenous alcohol on motility of the duodenum and of the sphincter of Oddi. Aust Ann Med 19: 24–29, 1970. 113 Robles EA, Mezey E, Halsted CH, Schuster MM: Effect of ethanol on motility of the small intestine. Johns Hopkins Med J 135: 17–24, 1974. 114 Rothschild MA, Oratz M, Schreiber SS: Alcohol, amino acids and albumin synthesis. Gastroenterology 67: 1200–1213, 1974. 115 Mendenhall CL, VA Cooperative Study Group: Alcoholic hepatitis. Clin Gastroenterol 10: 417–441, 1981. 116 Blackburn GL, Thronton PA: Nutritional assessment of the hospitalized patient. Med Clin N Am 63: 1103–1115, 1979. 117 Bistrian BR, Blackburn GL, Sherman S: Therapeutic index of nutritional depletion in hospitalized patients. Surg Gynecol Obstet 141: 512–516, 1975. 118 Rothschild MA, Oratz M, Schreiber SS: Effects of nutrition and alcohol on albumin synthesis. Alcoholism: Clin Exp Res 7: 28–30, 1983. 119 Nesrallah SM, Galambos JT: Amino-acid therapy of alcoholic hepatitis. Lancet 2: 1276–1277, 1980. 120 Koretz RL: What supports nutritional support Digest Dis Sci 29: 577–588, 1984. 121 Uribe M, Marquez MA, Mala J, Guevara L, Garcia-Ramos G, Ramos C: Treatment of chronic portal systemic encephalopathy with vegetable protein diets. Gastroenterology 79: 1128 (abstr) 1980. 122 Galambos JT: Alcoholic liver disease, new aspects of an old problem. Schweiz Med Wochenschr 108: 1050–1052, 1978. 123 Naccarato R, Messa P, D'Angelo A, Fabris A, Messa M, Chiar-amonte M, Gregolin C, Zanon G: Renal handling of sodium and water in early chronic liver disease. Gastroenterology 81: 205–210, 1981. 124 Epstein M: Renal sodium handling in cirrhosis. Semin Nephrol 3: 225–240, 1983. 125 Wilkinson SP; Hepato-renal Disorders. New York , Marcel Dekker, 1982. 126 Vesin P: Late functional renal failure in cirrhosis with ascites: pathophysiology, diagnosis, and treatment, in GA Martini, S Sherlock (eds): Aktuelle Probleme de Hepatologie. Stuttgart , Georg Thieme Verlag, pp 98-109, 1962. 127 Earley LE: Conclusive remarks and presentation of diagnostic criteria of hepatorenal syndrome, in E Bartoli, Chiandussil (eds): Hepatorenal Syndrome. Padoa , Italy , Piccin Medical Books, p 256, 1979. 128 Koppel MH, Coburn JW, Minis MM: Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease. N Engl J Med 280: 1367–1371, 1969. 129 Iwatsuki S, Popoutzer MM, Corman JL: Recovery from hepatorenal syndrome after liver transplantation. N Engl J Med 89: 1155–1160, 1973. 130 Witte MH, Witte CL, Jacobs S, Rut R: Peritoneovenous (Le-Veen) shunt. Control of renin-aldosterone system in cirrhotic ascites. J Am Med Assoc 239: 31–33, 1978. 131 Bichet D, Szatolowicz V, Chaimowitz V, Shrier RW: Role of vasopressin in the abnormal water excretion in cirrhotic man. Ann Intern Med 96: 413–417, 1982. 132 Richet D, van Putten V, Schrier R: Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhotic patient. N Engl J Med 307: 1552-1557, 1982. 133 Gordon JA, Anderson RJ: Hepatorenal syndrome. Semin Nephrol 1: 37–42, 1981. 134 LeVeen HH, Brown T, D'Ovidio NG: Surgical treatment of ascites. Ann Surg 14: 107–110, 1980. 135 Conn HO: The rational management of ascites, in H Popper, F Schaffher (eds): Progress in Liver Diseases. New York , Grune & Stratton, pp 269-288, 1972. 136 Shear L, Ching S, Gabuzda GJ: Compartmentalization of ascites and edema in patients with hepatic cirrhosis. N Engl J Med 282: 1391–1396, 1970. 137 Rimola A, Soto R, Bovy F, Arroyo V, Piera C, Rodes J: Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 4: 53–58, 1984. 138 Lebrec D, DeFleury P, Rueff B, Nahum H, Benhamou J-P: Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 79: 1139–1144, 1980. 139 Galambos JT: Esophageal variceal hemorrhage. Semin Liver Dis 2: 211–226, 1982. 140 Fogel MR, Knauer CM, Andres LL, Mahal AS, Stern DET, Kemeny MJ, Rinki MM, Walker JE, Siegmund D, Gregory PB: Continuous intravenous vasopressin in active upper gastrointestinal bleeding. Ann Intern Med 96: 565–569, 1982. 141 Kravetz D, Bosch J, Teres J, Bruix J, Rimola A, Rodes J: Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology 4: 442–446, 1984. 142 Freeman JG, Lishman AH, Cobden I: Controlled trial of terli-pressin (glypressin) versus vasopressin in the early treatment of oesophageal varices. Lancet 2: 66–68, 1982. 143 Bell RH, Miyai K, Orloff MJ: Outcome in cirrhotic patients with acute alcoholic hepatitis after emergency portacaval shunt for bleeding esophageal varices. Am J Surg 147: 78–84, 1984. 144 Graham DY, Lacey Smith J: The course of patients after variceal hemorrhage. Gastroenterology 80: 800–809, 1981. 145 Clark AW, Westaby D, Silk DBA, Dawson JL, MacDougall BRD, Mitchel KJ, Strunin L, Williams R: Prospective controlled trial of injection sclerotherapy in patients with cirrhosis and recent variceal haemorrhage. Lancet 2: 552–554, 1980. 146 MacDougall BRD, Theodossi A, Westaby D, Dawson JL: Increased long-term survival in variceal haemorrhage using injection sclerotherapy: results of a controlled trial. Lancet 1: 124–127, 1982. 147 Terblanche J, Kahn D, Campbell JAH, Boraman PC, Jonker MAT, Wright J: Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. Lancet 2: 1328–1332, 1983. 148 Reynolds TB: What to do about esophageal varices. N Engl J Med 309: 1575–1577, 1983. 149 Brooks WS: Variceal sclerotherapy an adjustment to shunting or an alternative? in Controversies in Gastrointestinal Endoscopy. Detroit , Am Society for Endoscopy, 1984. 150 Lebrec D, Poynard T, Bernuau J, Bercoff E, Nouel O, Capron J-P, Poupon R, Bouvry M, Rueff B, Benhamou J-P: A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 4: 355–358, 1984. 151 Sarph IJ, Tamawski A, Malki A, Mason GR, Mach T, Ivey KJ: Portal hypertension and gastric mucosal injury in rats. Effects of alcohol. Gastroenterology 84: 987–993, 1983. 152 Jackson FC, Perrin ER, Felix WR, Smith AG: A clinical investigation of the portacaval shunt V. Survival analysis of the therapeutic operation. Ann Surg 174: 672–701, 1971. 153 Grace ND: The misuse of cimetidine in patients with cirrhosis. Hepatology 3: 124–125, 1983. 154 Welsh R, Douglas A, Cohen S, Lovber A, Melnyk C, Bliss C, Zuckerman E, Crossley R, Christiansen P, Kern F: Effect of cimetidine on upper gastrointestinal hemorrhage. Gastroenterology 80: 1313 (abstr) 1981. 155 Feely J, Wilkinson GR, Wood AJJ: Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med 304: 692–695, 1981. 156 Henderson JM, Ibrahim SZ, Millikan WJ, Santi M, Warren WD: Cimetidine does not reduce blood flow in cirrhosis. Hepatology 3: 919–922, 1983. 157 MacDougall BRD, Williams R: Gastric acid reflux in the pathogenesis of variceal hemorrhage: a double blind trial of cimetidine treatment. Hepatology 3: 69–73, 1983. 158 Johnson GE: Oesophageal transection and devascularization procedures, in R Williams, D Westaby, BRD MacDougall (eds): Variceal Bleeding. London , The Royal Society of Medicine, 1982. 159 Mikhailidis DP, Barrades MA, Chnstofides J, Jeremy JY: Dan-dona P (letter). Hepatology 4: 573–574, 1984. 160 Pope CE. Involvement of the esophagus by infections, systemic illness and physical agents, in MH Sleisenger, JS Fordtran (eds): Gastrointestinal Disease. Philadelphia , WB Saunders, p 501. 161 Feller A, Rakeke J, Uchida T: Alcoholic cirrhosis complicated by acute viral hepatitis. Hepatology 18D (abstr) 1981. 162 Dienstag JL: Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85: 439–462, 1983. 163 Demeo AN, Anderson BR: Defective chemotaxis associated with a serum inhibitor in cirrhotic patients. N Engl J Med 286: 735–740, 1972. 164 van Epps DE, Palmer DL, Williams RC: Characterization of serum inhibitors of neutrophil chemotaxis associated with anergy. J Immunol 113: 189–198, 1974. 165 Altura BM, Hershey SG: Sequential changes in reticuloendothelial system function after acute hemorrhage. Proc Soc Exp Biol Med 139: 935–939, 1972. 166 Grieco MH, Capra JD, Paderon H: Reduced serum beta K/la globulin levels in extrarenal disease. Am J Med 51: 340–352, 1971. 167 Simberkoff M, Moldover N, Weiss G: Bactericidal and opsonic activity of cirrhotic ascites and nonascitic peritoneal fluid. J Lab Clin Med 91: 831–839, 1978. 168 Adams HG, Jordan C: Infections in the alcoholic. Med Clin N Am 68: 179–200, 1984. 169 Correia JP, Conn HO: Spontaneous bacterial peritonitis: endemic or epidemic Radiat Clin N Am 59: 963–985, 1975. 170 Gitlin N, Stauffer JL, Silvestri RC: The pH of ascitic fluid in the diagnosis of spontaneous bacterial peritonitis in alcoholic cirrhosis. Hepatology 2: 408–411, 1982. 171 Hoef JC, Canawati HN, Sapico EL: Spontaneous bacterial peritonitis. Hepatology 2. 399-407, 1982. 172 Conn HO: Acidic ascitic fluid: a leap forward (or a step?). Hepatology 2: 507–510, 1982. 173 Hoefs JC: Increase in ascites white blood cell and protein concentrations during diuresis in patients with chronic liver disease. Hepatology 1: 249–254, 1981. 174 Achord JL: Making an early diagram of spontaneous bacterial peritonitis. DrugTher Feb: 49-56, 1983. 175 Runyon BA, Hoefs JC: Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid. Hepatology 4: 447–450, 1984. 176 Fischer JF, Baldessanni RJ: Pathogenesis and therapy of hepatic coma, in H Popper, F Schaffner (eds): Progress in Liver Disease, vol 5. New York , Grune & Stratton, pp 363-397, 1976. 177 Schafer DF, Jones EA: Hepatic encephalopathy and the γ-aminobutyric acid neurotransmitter system. Lancet 2: 18–20, 1982. 178 Zaki AE, Ede R, Davis M, Williams R: Experimental studies of blood brain barrier permeability in acute hepatic failure. Hepatology 4: 359–363, 1984. 179 Crossley JR, Williams R: Progress in the treatment of chronic portasystemic encephalopathy. Gut 25: 85–98, 1984. 180 Egberts EH, Hamster W, Jurgens P, Schumacher H, Fondalinski G, Reinhard U, Schomerus H: Effect of branched chain amino acids on latent portal-systemic encephalopathy, in M Walser, JR Williams (eds): Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids. New York , Elsevier/North-Holland, pp 453-463, 1981. 181 Fiaccadori F, Ghinelli F, Pelosi G, Sacchini D, Vaona GL, Zeneroli ML, Rocchi E, Santunione V, Gibertini P, Ventura E: Selective amino acid solutions in hepatic encephalopathy treatment (a preliminary report). Ric Clin Lab 10: 411–422, 1980. 182 Cena FB, Cheung NK, Fischer JE, Kaplowitz N, SchifT ER, Dienstag JL, Mabry CD, Leevy CM, Kjernan T: A multicenter trial of branched chain enriched amino acid infusion (F080) in hepatic encephalopathy (HE). Hepatology 2: 699 (abstr) 1982. 183 Hagenfeldt L, Ericksson S, Wahten J: Is the administration of branched chain amino acids effective in the treatment of hepatic encephalopathy, in Fourth Symposium on Intensive Care in Hepatology and Gastroenterology, Marseilles, September 2830, 1981. 184 Rossi-Fanelli F, Rjggio O, Cangjano C, Cascino A, DeConciliis D, Merli M, Stortoni M, Giunchi G, Dapocaccia L: Branched-chain amino acids vs lactulose in the treatment of hepatic coma. Digest Dis Sci 27: 929–935, 1982. 185 Michel H, Pomier-Layrargues G, Duhamel O, Lacombe B, Cuilleret G, Bellet H: Intravenous infusion of ordinary and modified amino-acid solutions in the management of hepatic encephalopathy. Gastroenterology 79: 1038 (abstr) 1980. 186 Wahren J, Denis J, Desurmont P, Eriksson LS, Escoffier J-M, Gauthier AP, Hagenfeldt L, Michel H, Opolon P, Paris J-C, Veyrac M: Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology 3: 475–480, 1983. 187 Horst D, Grace ND, Conn HO, SchifT E, Schenker S, Viteri A, Law D, Atterbury CE: Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology 4: 279–287, 1984. 188 Vierling JM: Epidemiology and clinical course of liver diseases: identification of candidates for hepatic transplantation. Hepatology 4: 845–945, 1984. 189 Baker AL, Jaspan JB, Haines NW, Hatfield GE, Krager PS, Schneider JF, The University of Chicago Medical Housestaff: A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients. Gastroenterology 80: 1410–1414, 1981. 190 Marshall AW, Graul RS, Morgan MY, Sherlock S: Treatment of alcohol-related disease with thioctic acid: a six month randomized double-blind trial. Gut 23: 1088–1093, 1982. 191 National Institutes of Health Consensus Statement Liver transplantation. June 20–23, 1983. Hepatoloty 4: 1075-1105, 1984. Citing Literature Volume9, Issue1January 1985Pages 66-82 ReferencesRelatedInformation